Search Results
Reflecting on Our Two-Day Strategy Session in Financial Institutions Group
In December 2023, the Financial Institutions Group held its annual strategic planning session, a two-day event challenging our bankers to collectively reflect on the year’s successes and challenges while charting a course for 2024 and beyond.
Q3 Private Placement Activity and M&A and Strategic Collaborations
Oppenheimer's Q3 update on VC, M&A, and BD&L activity for the biopharma sector.
Private Placement Activity and M&A and Strategic Collaborations
We are happy to share Oppenheimer's Quarterly Private Placement Insights as well as our M&A and Strategic Collaborations Insights. Spoiler Alert: The positive momentum of 2023 has carried over into 2024.
Placement Agent on Skye Bioscience's $50MM Private Placement Financing
Oppenheimer &. Co. Inc. acted as Placement Agent on Skye Bioscience’s $50MM Private Placement Financing
Placement Agent on Skye Bioscience's $40MM Private Placement
Oppenheimer &. Co. Inc. acted as Placement Agent on Skye Bioscience’s $40MM Private Placement
Placement Agent on Q32 Bio's Private Placement Financing
Oppenheimer &. Co. Inc. acted as Placement Agent on Q32 Bio’s $42MM Private Placement Financing
Placement Agent on Protara Therapeutics' $45MM Private Placement Financing
Oppenheimer &. Co. Inc. acted as Placement Agent on Protara Therapeutics’ $45MM Private Placement Financing
Placement Agent on Olema Pharmaceuticals' Private Placement Financing
Oppenheimer & Co. Inc. acted as Placement Agent on Olema Pharmaceuticals’ $250MM Private Placement Financing
Oppenheimer Healthcare Q1 Snapshot
Oppenheimer's 2023 Year-in-Review and 2024 Outlook for Private Placement Activity and M&A and Strategic Collaborations are now available upon request.
M&A Adviser to Alchemist Learning & Development on Securing Significant Investment from Horizon Capital
Oppenheimer’s European Human Capital Management Investment Banking Team is pleased to announce it has advised Rockpool Investments' portfolio company Alchemist Learning & Development on securing significant investment from Horizon Capital